TurboID, miniTurbo, Split-TurboID and ProtA-TurboID BioID, BioID2, and Split-BioID have relatively long labeling times (1618 h), which may affect the labeling of transiently interacting proteins and protein functions, leading to false-positive or false-negative results
The European Medicines Agency (EMA) European Public Assessment Reports (EPARs) provide useful supporting scientific information for many licensed medicines and may be consulted as background references
I just posted a follow-up to my piece about Tirzepatide and microdosing, Mollen wrote via her Instagram Story at the time
Patients often report appetite loss and insomnia as the most significant effects
Energy levels typically begin improving during this phase for a reason that might seem counterintuitive: even though caloric intake is falling, metabolic efficiency is improving
PetCare